Korro Bio is a biotechnology company specializing in gene therapy whose RNA editing approach leverages already natural occurring processes.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
01/05/2022 | Series B-1 | $45.13MM | $xx.xx | $29.04B | Alexandria Venture Investments, Atlas Venture, Cormorant Asset Management, Eventide Asset Management, Fidelity, Invus, Monashee Investment Management, Mp Healthcare Venture Management, Nea, Point72, Qiming Venture Partners, Sixty Degree Capital, Surveyor Capital, Verition Fund Management, Wu Capital | |
Price per Share
$xx.xx
Shares Outstanding
17,289,273
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Venture Investments, Atlas Venture, Cormorant Asset Management, Eventide Asset Management, Fidelity, Invus, Monashee Investment Management, Mp Healthcare Venture Management, Nea, Point72, Qiming Venture Partners, Sixty Degree Capital, Surveyor Capital, Verition Fund Management, Wu Capital
|
||||||
01/05/2022 | Series B-2 | $45.12MM | $xx.xx | $29.04B | Alexandria Venture Investments, Atlas Venture, Cormorant Asset Management, Eventide Asset Management, Fidelity, Invus, Monashee Investment Management, Mp Healthcare Venture Management, Nea, Point72, Qiming Venture Partners, Sixty Degree Capital, Surveyor Capital, Verition Fund Management, Wu Capital | |
Price per Share
$xx.xx
Shares Outstanding
16,232,013
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Venture Investments, Atlas Venture, Cormorant Asset Management, Eventide Asset Management, Fidelity, Invus, Monashee Investment Management, Mp Healthcare Venture Management, Nea, Point72, Qiming Venture Partners, Sixty Degree Capital, Surveyor Capital, Verition Fund Management, Wu Capital
|
||||||
09/10/2020 | Series A | $91.5MM | $xx.xx | $17.48B | Alexandria Venture Investments, Atlas Venture, Cormorant Asset Management, Mp Healthcare Venture Management, Nea, Qiming Venture Partners, Surveyor Capital, Wu Capital | |
Price per Share
$xx.xx
Shares Outstanding
40,848,220
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Venture Investments, Atlas Venture, Cormorant Asset Management, Mp Healthcare Venture Management, Nea, Qiming Venture Partners, Surveyor Capital, Wu Capital
|
||||||
12/31/2019 | Series Seed 3 | $10.12MM | $xx.xx | $2.99B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,780,769
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
05/24/2019 | Series Seed 1 | $4MM | $xx.xx | $1.2B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
05/24/2019 | Series Seed 2 | $2MM | $xx.xx | $1.2B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|